Questions and answers on workup diagnosis and risk stratification: a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Files
Publication date
2021-04-07
Authors
ESC Scientific Document Group
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
cc_by_nc
Abstract
Keywords
Acute cardiac care, Acute coronary syndrome, Angioplasty, Anticoagulation, Antiplatelet, Apixaban, Aspirin, Atherothrombosis, Betablockers, Bivalirudin, Bleedings, Bypass surgery, Cangrelor, Chest pain unit, Clinical cases, Clopidogrel, Dabigatran, Diabetes, Dual antithrombotic therapy, Early invasive strategy, Edoxaban, Enoxaparin, European Society of Cardiology, Fondaparinux, Glycoprotein IIb/IIIa inhibitors, Guidelines, Heparin, High-sensitivity troponin, MINOCA, Myocardial infarction, Myocardial ischaemia, Nitrates, Non-ST-elevation myocardial infarction, Platelet inhibition, Prasugrel, Recommendations, Revascularisation, Rhythm monitoring, Rivaroxaban, Stent, Ticagrelor, Triple therapy, Unstable angina, Cardiology and Cardiovascular Medicine, Journal Article
Citation
ESC Scientific Document Group 2021, 'Questions and answers on workup diagnosis and risk stratification : a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation', European heart journal, vol. 42, no. 14, pp. 1379-1386. https://doi.org/10.1093/eurheartj/ehaa602